How VA clinicians treat veterans’ PTSD while managing suicide risk, using shared decisions, safety planning, and phase-based trauma therapies.
|Podcasts|June 19, 2020
Discovering Psychiatry throughout the 5 Boroughs
Advertisement
Flexibility; creativity. Maryann Popiel, MD, discusses how developments in mental health and an evolving public perception of psychiatry have influenced her practice in an urban community such as the Bronx, and describes career opportunities and a potential career path for psychiatrists in Greater New York City.
Presented by: Maryann J. Popiel, M.D.
Chair, Department of Psychiatry and Behavioral Sciences Department of Psychiatry at Jacobi Medical Center. Dr. Maryann J. Popiel is a psychiatrist for Jacobi and North Central Bronx Hospital with more than 30 years’ experience.
Advertisement
Related to this article
RADIANT phase 2 shows once-daily remlifanserin eases Alzheimer’s psychosis symptoms with placebo-like safety, advancing pivotal trials.
Discover how integrated psychotherapy—CBTp, family support, and relapse plans—boosts schizophrenia recovery alongside antipsychotics.
FDA grants Breakthrough Device status to NET Recovery’s tACS wearable, aiming to curb cocaine and meth use and close a major treatment gap.
Learn how IPV shapes mental health from pregnancy to adulthood, and how clinicians assess risk, plan safety, and treat victims and perpetrators.
Early trial shows investigational orexin-2 agonist ALKS 7290 improves adult ADHD symptoms in 14 days, with tolerable safety, paving way for phase 2.
Open-label extension data show fasedienol appears well tolerated and steadily improves social anxiety scores with as-needed intranasal use, as Vistagen plans FDA discussions.
A case report and review of 13 similar cases suggest that late-onset clozapine neutropenia may sometimes reflect neutrophil margination rather than marrow suppression, with corticosteroids, granulocyte colony-stimulating factor, or lithium as possible, carefully monitored paths to continuing treatment.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder
2
The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin
3
Using Psychotherapy for the Prevention of Relapse in Schizophrenia
4
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
5